糖尿病血液透析患者における通常量レパグリニドとDPP‒4 阻害薬併用の安全性，有用性と両薬剤による透析中血糖低下の検討

Therapeutic Research

No data available.

Please log in to see this content.

You have no subscription access to this content.

The full text of this article is not currently available.

糖尿病血液透析患者における通常量レパグリニドとDPP‒4 阻害薬併用の安全性，有用性と両薬剤による透析中血糖低下の検討

Rent:

Rent this article for

JPY

Authors: 今中俊爾¹, 他

View Affiliations

Source: Therapeutic Research Volume 38, Issue 6, 643 - 648 (2017)

Publisher: ライフサイエンス出版

There is no abstract available for this article.